Drug major Lupin today said it has launched Solosec, an oral antibiotic used in treating bacterial vaginosis (BV) in women, in the US market.
The company has launched Solosec oral granules in the American market after having received approval from the US Food and Drug Administration (USFDA) earlier, Lupin said in a statement.
With more than four million women treated for BV in the US annually, and only 50 per cent completing 5 to 7 day treatments, there is a clear need for an effective, single-dose oral treatment, Lupin Chief Executive Officer Vinita Gupta said in a statement.
According to the company, it only takes one packet of Solosec to complete treatment and the single dose stays in the body and continues to treat BV for four days without an alcohol restriction.
Solosec does not inhibit the enzyme that metabolises alcohol, it added.
Shares of Lupin were trading 0.60 per cent down at Rs 773.55 on the BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app